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0022-2836 © 2010 Elsevier Ltd. Open accThe interaction between the calcium-binding protein S100A4 and the C-
terminal fragments of nonmusclemyosin heavy chain IIA has been studied by
equilibrium and kinetic methods. Using site-directed mutants, we conclude
thatCa2+ binds to theEF2domainof S100A4withmicromolar affinity and that
theKd value forCa
2+ is reducedby several orders ofmagnitude in the presence
of myosin target fragments. The reduction in Kd results from a reduced
dissociation rate constant (from 16 s−1 to 0.3 s−1 in the presence of coiled-coil
fragments) and an increased association rate constant. Using peptide
competition assays and NMR spectroscopy, we conclude that the minimal
binding site on myosin heavy chain IIA corresponds to A1907-G1938;
therefore, the site extends beyond the end of the coiled-coil region of myosin.
Electron microscopy and turbidity assays were used to assess myosin
fragment filament disassembly by S100A4. The latter assay demonstrated
that S100A4 binds to the filaments and actively promotes disassembly rather
than just binding to the myosin monomer and displacing the equilibrium.
Quantitative modelling of these in vitro data suggests that S100A4 concentra-
tions in the micromolar region could disassemble myosin filaments even at
resting levels of cytoplasmic [Ca2+]. However, for Ca2+ transients to be
effective in further promoting dissociation, the elevated Ca2+ signal must
persist for tens of seconds. Fluorescence recovery after photobleaching of
A431/SIP1 cells expressing green fluorescent protein–myosin IIA, immobi-
lised on fibronectin micropatterns to control stress fibre location, yielded a
recovery time constant of around 20 s, consistent with in vitro data.© 2010 Elsevier Ltd. Open access under CC BY license.ress: crb5@le.ac.uk.
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1005S100A4-Myosin IIA InteractionsIntroduction
Over the last two decades, there has been much
interest in the role of the S100 Ca2+-binding protein
family in the regulation of cellular events.1,2 Identi-
fying the specific targets of each of the 24 members3
and deducing their mechanisms of action in vitro and
in vivo remain to be a challenge. This is exemplified by
S100A4 (also known as Mts1, metastasin, p9Ka,
pEL98, calvasculin, and Fsp-1), which has been
implicated in a wide range of cellular events and
numerous diseases and binds to several different
targets in vitro.4–6 In particular, following early
work,7–9 there have been many studies on the
interaction of S100A4 and nonmuscle myosin heavy
chain IIA (NM-MHC IIA). In the presence of Ca2+,
S100A4 promotes the disassembly of NM-MHC IIA
filaments and inhibits the assembly of monomeric
NM-MHC IIA into filaments.10 Using NM-MHC IIA
rods as a model system, Li et al. concluded that
S100A4 bound tightly to the monomeric myosin tail
to increase its critical concentration, thus inhibiting
filament formation.11 At 20 mM NaCl, S100A4 was
ineffective at dissociating rod filaments, but it did
bind to rods with micromolar affinity.11 However, it
remains an open question as to whether S100A4
depolymerises myosin or rod filaments just by
sequestering the monomeric species and allowing
the monomer–polymer equilibrium to readjust, or
whether S100A4 binds to the myosin rod region in
filaments and actively promotes depolymerisation.
S100 proteins contain two EF-hand Ca2+ binding
sites, but the N-terminal domain (EF1) is a pseudo
EF-hand. It contains 14 residues—instead of the
usual 12 residues—in the Ca2+ binding loop, and,
apart from glutamate 33, backbone carbonyl resi-
dues provide Ca2+ binding ligands instead of side
chains. Literature Kd values for Ca
2+ binding to
S100A4 show a disparate range from themicromolar
region to the millimolar region.12–18 Garrett et al.16
and Malashkevich et al.17 determined two classes of
site by various methods and considered the higher-
affinity site to represent Ca2+ binding to the
canonical EF2 hand, with the weaker site represent-
ing the pseudo EF1 hand. However, detailed studies
on the related protein calbindin D9k indicated that
both EF1 and EF2 sites bound Ca2+ with comparable
affinities and that there was cooperativity between
them.19,20 These results indicated that a pseudo EF1
site can potentially bind Ca2+ with a very high
affinity (10−8 M) and, therefore, the weaker site
cannot be assumed to be EF1 without additional
evidence. Interestingly, NMR titration studies on
S100A4 indicated that the pseudo EF1 hand may
bind Ca2+ more tightly than EF2, as some residues in
the N-terminus were perturbed at lower Ca2+ ratios
compared with those in the C-terminus.15
Apart from the different methods used to study
Ca2+ binding, which have sensitivities over differentconcentration ranges, part of the variability in Kd
values in the literature may arise from the self-
association of S100A4. There is a general
consensus12,13,17,21,22 that S100A4 exists predomi-
nantly as a dimer at micromolar concentrations
(indeed, this can lead to difficulties in interpreting
literature values for stoichiometries quoted as
‘moles of Ca2+ bound per mole of S100A4’ if the
latter is not stated explicitly as being per monomer
or per dimer). In the absence of Ca2+, monomeric
S100A4 can be detected at protein concentrations
below 2 μM.21 At concentrations exceeding 20 μM
S100A4 in the presence of Ca2+, tetrameric and
higher aggregates become significant.17,21,22 Secreted
S100A4 exists in these higher-order states, possibly
aided by cysteine disulphide cross-linking, to effect
additional extracellular functions.23 S100A4 crystals,
grown in the presence of Ca2+, revealed a tetrameric
structure in which the C-terminal extension of one
S100A4 monomer bound to the target binding site of
an S100A4 monomer in the apposing dimer.18 While
Ca2+ is not required for dimerisation or further
oligomerisation, Ca2+ tends to stabilise higher-order
quaternary structures; therefore, the measured Ca2+
affinity will depend on the protein concentration
used. Thermodynamic coupling requires the higher-
order oligomerisation states to bind Ca2+ more
tightly. Here, we reexamine the Ca2+ binding
properties of S100A4, including mutant E33Q and
D63N constructs, which are compromised in the EF1
and EF2 Ca2+ binding loops, respectively.24
Comparison of the high-resolution NMR structure
of S100A4 in the absence of Ca2+ (Protein Data Bank
code 1M3125) with crystal structures obtained in the
presence of Ca2+ (Protein Data Bank codes 3C1V,18
2Q91,17 and 3CGA26) shows that, in common with
other S100 proteins, Ca2+ binding to EF2 induces a
60° reorientation of helix III to expose a hydrophobic
surface that constitutes at least part of the target
binding site. In the absence of Ca2+, S100A4 shows a
very low affinity for many of its targets,2 including
the binding of NM-MHC IIA and its tail
fragments.7,8,11 Thermodynamic linkage requires
the target-bound form of S100A4 to bind Ca2+
more tightly than in the absence of a target
protein.14,16 We extend these studies by examining
the Ca2+-dependent kinetics of target binding and
the kinetics of Ca2+ dissociation from S100A4 in the
absence and in the presence of targets. These studies
are pertinent to assessing the extent of interaction of
S100A4 with NM-MHC IIA at resting cytoplasmic
[Ca2+] and the changes induced by spikes, waves, or
a more prolonged elevation of [Ca2+] on excitation.
Previous reviews have commented on the apparent
anomaly (the S100 dilemma27) that many S100
proteins bind Ca2+ in the 10–50 μM range, which
is 2 orders of magnitude higher than the time-
averaged cytoplasmic [Ca2+] of eukaryotic cells, and
barely reach peak excitation.2
1761 - .....QINTDLNLERSHAQKNENARQQLERQNKELKVKLQEMEGTV - 1801
1802 - KSKYKASITALEAKIAQLEEQLDNETKERQAACKQVRRTEKKLKDV - 1847
1848 - LLQVDDERRNAEQYKDQADKASTRLKQLKRQLEEAEEEAQRANASR - 1893
1894 - RKLQRELEDATETADAMNREVSSLKNKLRRGDLPFVVPRRMARKGA - 1939
1940 - GDGSDEEVDGKADGAEAKPAE                          - 1960
Fig. 1. Sequence of C-terminal human NM-MHC IIA fragments and peptides. The His-tagged expressed fragments
M200 and M111 contained an N-terminal fusion comprising residues MRGSHHHHHGS. The sequence shown
corresponds to M200 (residues Q1761-E1960; native C-terminus). M111 starts at residue Q1850 (red). The M32 peptide
(A1907-G1938) is underlined, M16N (D1908-R1923) is shown in green, and M15C (G1924-G1938) is shown in blue.
Residues in the a and d heptad repeat positions of the coiled coil (generally hydrophobic) are shown in boldface. The
nonhelical C-terminus region is shown in italics. Note that the numbering system is one residue shorter than that
originally used by Kriajevska et al. and corresponds to the current nonmuscle myosin IIA database nomenclature (NCBI
reference sequence NM_002473.4).9 Thus, M200 is equivalent to the Hmyo4-3B fragment.9 Note that the M200 and M111
preparations contain a V1913I substitution.
1006 S100A4-Myosin IIA InteractionsOur kinetic studies are also used to redefine the
minimal binding fragment of the NM-MHC IIA tail
(Fig. 1). Using a series of overlapping fragments and
a blot overlay assay, Kriajevska et al. previously
mapped the S100A4 binding site of nonmuscle
myosin IIA to a 29-amino-acid region near the C-
terminus (residues 1908–1936 in the current num-
bering system).9 Subsequently, Malashkevich et al.
reported only around a 2-fold difference in binding
constant between a shorter peptide comprising
residues 1908–1923 (identical with M16N in the
present study) and longer fragments (residues 1851–
1960 and 1893–1923), and they concluded that the
former represented the minimal S100A4 binding
site.17 Here we reexamine the properties of myosin-
based peptides' binding to S100A4 and find that the
fluorescein tag, as used by Malashkevich et al.,
makes a large contribution to binding energy and
that the binding site extends beyond the “minimal”
region of residues 1908–1923.17
Results
Ca2+ binding to S100A4 and mutant constructs
Malashkevich et al. investigated Ca2+ binding to
S100A4 using isothermal titration calorimetry (ITC)
and reported that, at 37 °C and 20 mM KCl, two
classes of site with Kd values of 3.3 μM and 54 μM at
positive and negative enthalpies, respectively, were
apparent.17 We obtained comparable results at 30 °C
(Fig. 2, Table 1) but found that the parameters of the
second site were not well defined. Under our
standard buffer conditions at 20 °C, the enthalpy
changes were smaller, and the second site was not
evident. At 10 °C, the first site became associated
with negative enthalpy but retained a similar Kd
value, while the second site remained undetectable.
While this might be caused by a change in affinity, it
is possible that the enthalpy change for the secondsite is small and masked by the first. In some
titrations at 10 °C, the ITC profile indicated positive
cooperativity. The variability in these titrations may
arise from differences in the small amounts of
contaminant Ca2+ present at the start of the titration.
Titration against ethylene glycol bis(b-aminoethyl
ether) N,N′-tetraacetic acid (EGTA) indicated that
about 20% of the S100A4 had prebound Ca2+
present. The measured stoichiometry of the higher-
affinity site was 0.8–0.9 Ca2+ per monomer (Table 1),
which, after allowance for the prebound Ca2+,
indicates that the high-affinity site corresponds to
a single EF hand. This conclusion, however,
depends on the accuracy of the S100A4 concentra-
tion determination (see Discussion).
In an attempt to assign the measured affinities to
the EF1 and EF2 sites, we examined S100A4
constructs in which an acidic side chain that
contributes to each of the Ca2+ binding sites was
mutated to its corresponding amide (E33Q and
D63N), as performed previously.24 The E33Q
construct showed some similarities with the wild-
type S100A4 in that it bound Ca2+ in the region of
1–10 μM, with an indication of cooperativity at
10 °C; however, the stoichiometry was reduced at
30 °C, suggesting that the protein may be less stable
(Fig. 2c; Fig. S1a). The D63N mutant bound Ca2+
much more weakly (Fig. 2d; Fig. S1b) and required
the protein concentration to be increased 4-fold for
ITC measurements. A Kd of 65–70 μM and positive
enthalpy were recorded at both 10 °C and 30 °C, but
the change in enthalpy with temperature was
similar to that of wild type. The interpretation of
these mutant constructs is not straightforward as it
appears that there is communication between the
EF1 domain and the EF2 domain. However, the
simplest explanation is that the higher-affinity site
observed by ITC with the wild type corresponds to
EF2 because this site is retained in the E33Q mutant.
In the D63N construct, the observed weaker Ca2+
binding could represent binding to EF1, but the size
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Fig. 2. ITC records for Ca2+ binding to S100A4 constructs: (a) 75 μMwild type at 30 °C; (b) 75 μMwild type at 10 °C; (c)
75 μM E33Q construct at 30 °C; (d) 300 μMD63N construct at 30 °C. For mutant constructs data at 10 °C, see Fig. S1. The
fitted lines in the bottom panels correspond to the data shown in Table 1. All preparations were dialysed against the same
buffer of 20 mM NaCl, 10 mM Hepes, and 2 mM DTT (pH 7.5).
1007S100A4-Myosin IIA Interactionsand temperature dependence of the enthalpy
change might also be explained by weak Ca2+
binding to EF2, since the other five Ca2+ coordinat-ing ligands remain intact in this mutant. The identity
of the Ca2+ binding sites was explored further using
kinetic methods.
Table 1. Analysis of ITC data for Ca2+ binding to S100A4
S100A4 n1 (Ca
2+ per monomer) K1K1d (μM) ΔH1 (cal mol
−1) N2 (Ca
2+ per monomer) K2K2d (μM) ΔH2 (cal mol
−1)
Wild type,
30 °C
0.83±0.2 1.7 (+1.7/−0.6) +1224±216 0.42±0.27 5.7±1.1 −1907±2210a
Wild type,
10 °C
0.95±0.014 1.6±0.4 (cooperative) −930±20 — — —
E33Q, 30 °C 0.33±0.03 10.9±1.9 +1643±162 — — —
E33Q, 10 °C 0.96±0.09 ∼1 cooperative b−83 — — —
D63N, 30 °C 0.54±0.01 68±1 +4136±43 — — —
D63N, 10 °C 0.44±0.01 65±3 +2584±62 — — —
a Standard error exceeds estimate. Therefore, this parameter remains ill-defined. Data were obtained as described in Fig. 2.
1008 S100A4-Myosin IIA InteractionsPreviously, we found that Ca2+ dissociates from
S100A4 with a rate constant of 20 s−1, as determined
by the change in intrinsic tyrosine fluorescence.18
S100A4 contains two tyrosine residues (one in each
of the EF-hand domains), and mutating each in turn
to phenylalanine enabled us to identify the source of
the signal change. Both Y19F and Y75F constructs
showed tyrosine fluorescence changes on Ca2+
dissociation with amplitudes about half that of the
wild type (Fig. S1c). However, the rate constants
were increased (Y19F, 113 s− 1; Y75F, 45 s−1),
suggesting some loss of stability of the Ca2+-bound
form with the mutants. We also examined the E33Q
and D63N mutants under similar conditions and
found that the D63N mutant gave no resolved
transient, suggesting that Ca2+ binding was weak
and/or its release was too fast to measure
(N400 s−1). On the other hand, the E33Q mutant
gave a transient that was similar in amplitude to the
wild type but with double the rate constant (Fig.
S1d; 49 s−1 cf. 22 s−1), indicative of a small loss in the
stability of the EF2 Ca2+ binding loop. The data are
consistent with the ITC data in that they indicate
that the D63N mutation leads to a marked weaken-
ing of Ca2+ binding and suggests that Ca2+
dissociation from EF2 is responsible for tyrosine
fluorescence change. On the other hand, tyrosine
residues in both the EF2 domain (Y75) and the EF1
domain (Y19) respond to the loss of Ca2+ from the
EF2 site (Fig. S1a), thus demonstrating communica-
tion between the two EF hands.
In order to increase the signal-to-noise ratio of the
Ca2+ dissociation transients, we used Quin-2 as
combined fluorescent indicator and high-affinity
chelator.19,20 These measurements confirmed that
Ca2+ dissociated from wild-type protein with a rate
constant of 16 s−1 (Fig. 3a; cf. 20 s−1 for the tyrosine
signal). Given the poor signal-to-noise ratio of the
tyrosine signal, the difference is barely significant
but may reflect the fact that the Quin-2 signal
represents at least a two-step sequential reaction
(Ca2+ dissociation from S100AS4, followed by rapid
binding to Quin-2). The E33Q mutant showed a
similar amplitude but with a slightly higher rate
constant (35 s−1), indicating that the EF2 Ca2+
binding site remained functional despite a compro-mised EF1 site. The D63N mutant showed a much
smaller transient that was just resolved (500 s−1) and
could represent Ca2+ release from the compromised
EF2 site with a 30-fold reduction in affinity, as
suggested by the ITC data. Ca2+ binding to EF1
therefore appears weaker than Ca2+ binding to EF2,
and its dissociation is too fast to measure by
stopped-flow methods in all constructs.
Some S100A4 preparations showed a second slow
phase of Ca2+ dissociation (generally b20% of the
signal) with a rate constant of 0.4–4 s−1. The
amplitude of the slow phase increased on storage
of S100A4 at 4 °C and probably arose from
oligomerisation and/or oxidation. This factor is
important to control for in Ca2+ dissociation
measurements in the presence of target peptides
(described below), where the observed rate con-
stants are comparable to this slow phase.
The amplitude of Quin-2 records contains infor-
mation on the amount of Ca2+ bound. In a separate
experiment, the Quin-2 fluorescence signal obtained
in the stopped-flow apparatus was calibrated by the
addition of known Ca2+ concentrations, and the
baseline fluorescence in the absence of contaminat-
ing Ca2+ (+1 mM EGTA) was determined. These
data indicated that the resolved signal corresponded
to one Ca2+ bound per S100A4 monomer (Fig. 3b),
again suggesting that EF2 alone is responsible for
this transient.
Myosin peptide binding to S100A4
The interaction of myosin tail fragments (M) with
S100A4 depends on [Ca2+], with little detectable
binding in the absence of Ca2+.2,7,17 Scheme 1
presents a minimal pathway describing the thermo-
dynamics and kinetics of this interaction, where
arrow lengths indicate the approximate position of
the equilibria involved.
Myosin peptides were used to investigate the
minimal S100A4 target site on the myosin heavy
chain. We confirmed that the fluorescein-tagged
peptide F-M16N bound to S100A4 using a fluores-
cence anisotropy assay16 and yielded an apparent K2
of 2.0 μM (assuming a 1:1 binding between each
S100A4 monomer and the peptide) in the presence
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Fig. 3. (a) Dissociation of Ca2+ from wild-type S100A4
(black), E33Q mutant (blue), and D63N mutant (red), as
monitored by Quin-2 fluorescence. Fits to a single
exponential yielded rate constants of 16 s−1, 35 s−1, and
500 s−1, respectively, but the D63N record had a small
amplitude, suggesting that most of the signal change was
too fast to measure. The records for the mutants were
vertically offset for clarity. (b) Ca2+ binding to S100A4 as
determined from the amplitude of the resolved transient
(k≈20 s−1) when 6.5 μM S100A4 was preincubated with
various added [Ca2+] and thenmixed with 100 μMQuin-2.
The amplitude was converted into a bound concentration
from an independent calibration using the same Quin-2
solution and known free [Ca2+]. The latter transients were
too fast to measure but gave a steady signal on the seconds
timescale. The continuous black line was computed for a
model with cooperative binding in which the first Ca2+
bound to EF2 of an S100A4 dimer with a Kd of 100 μM and
the second Ca2+ bound to EF2 of an S100A4 dimer with a
Kd of 1.7 μM. The blue line was computed for a model with
an EF1 binding site with Kd=0.25 μM that was optically
silent in the Quin-2 assay (i.e., dissociation too fast to
measure) and an EF2 site with Kd=5 μM. While either
model could account for the data, the measured stoichi-
ometry from ITC (Table 1) favors the cooperative model.
Scheme 1. Ca2+ and myosin peptide (M) binding to
S100A4.
1009S100A4-Myosin IIA Interactionsof Ca2+ (Fig. 4a). This value is very close to that
reported by Malashkevich et al., who found a K2 of
0.89 μM in 20 mM KCl when [S100A4] was defined
in terms of dimer concentration.17 However, in our
titration, we noted about a 35% quench in the total
fluorescein fluorescence intensity (Ivv+2Ivh; see
Materials and Methods) on binding, which means
that the observed anisotropy is weighted towards
the unbound state. Consequently, the true Kd is
overestimated by about this percentage (i.e., our
corrected K2=1.3 μM with respect to monomer
concentration; Table 1). More importantly, we found
that the unlabelled M16N peptide is a very poor
competitor of F-M16N and binds with a K2
of≥100μM(Fig. 4b). A larger peptide,M32, however
binds with a K2 of around 3 μM, as determined by
competition with F-M16N binding. In view of the
discrepancy with the results of Malashkevich et al. in
the length of the “minimal” peptide, we checked the
sequence of our commercialM16N sample and found
it to be correct.17 We also checked for M16N binding
to S100A4 using other assays (see the text below) and
confirmed that it was at least an order of magnitude
weaker than M32 binding. In the absence of Ca2+,
F-M16N binding was undetectable (b10% change in
anisotropy), indicating that K0 is N300 μM (Fig. 4a).
We therefore conclude that the fluorescein moiety
contributes to much of the binding energy of F-M16N
on interaction with S100A4 in the presence of Ca2+,
and that the “minimal” binding peptide encom-
passes at least the region 1907–1938 (≡M32) of
myosin heavy chain IIA.
The hypothesis that the fluorescein of F-M16N
interacts directly with S100A4 was also supported by
the change in its fluorescence emission intensity on
binding, indicative of a changed environment of the
fluorescein group. This change was exploited to
determine the kinetics of F-M16N binding to S100A4
by stopped-flow methods (Fig. 4c). The observed
pseudo first-order rate constant for binding (kobs=k2
[S100A4]+k−2) as a function of [F-M16
N] yielded
association (k2) and dissociation (k−2) rate constants of
4.9 μM−1 s−1 and 6.2 s−1, respectively (Fig. 4d). The
dissociation rate constant was confirmed by
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Fig. 4. (a) The binding of fluorescein-labelled M16N myosin peptide (0.1 μM) to S100A4 based on fluorescence
anisotropy. Titration (circles) was carried out in 20 mMNaCl, 10 mMHepes, 1 mMMg2+, and 100 μMCa2+ at pH 7.5 and
20 °C. The fitted hyperbola yielded an apparent Kd of 2.0±0.23 μM (see the text for correction). At the end of the titration,
EGTA was added to 1 mM, causing the peptide to dissociate (square datum). (b) Displacement of F-M16N (5 μM) from
S100A4 (5 μM) by increasing [M32] (circles) or [M16N] (squares). The continuous line corresponds to a Kd of 3 μM for M32
binding to S100A4, as determined by a fit to a competitive single binding site equation, using the Excel solver routine to
minimise the variance. The continuous line deviated systematically from the data when the modelled Kd for M32 was
increased or reduced by 50% of its value. M16N caused little displacement of its fluorescent counterpart even at a
concentration of 200 μM. Modelling to a competitive binding equation indicates that the Kd of M16
N for S100A4
is ≥100 μM (broken line). (c) Stopped-flow record of 0.1 μM F-M16N binding to 25 μM S100A4 monitored by fluorescein
emission intensity. A fit to a single exponential yields kobs=138 s
−1. (d) Dependence of the pseudo first-order rate constant
kobs for F-M16
N (0.1 μM) binding as a function of S100A4 concentration. The rate constant of 7.7 s−1 (open square) at zero
[S100A4] was obtained by the displacement of FM16N from S100A4 by excess M32 (see Fig. S2a). The fitted straight line
yields kon=4.9 μM
−1 s−1 and koff=6.2 s
−1. At concentrations above 25 μM S100A4, the graph became nonlinear and
reached a maximum kobs of 150 s
−1.
1010 S100A4-Myosin IIA Interactionsmeasuring the rate constant for the displacement of F-
M16N with a large excess of M32 (Fig. S2a). These
rate constants yield a K2 of 1.3 μM, identical with
the corrected value from the equilibrium anisotropy
assay (Table 2). When a solution of 0.1 μM F-M16N
and 10 μM S100A4 in 50 μM Ca2+ was mixed with
1 mM EGTA, a rise in fluorescence was noted with
a kobs of 9.4 s
−1 (Fig. S2b). We assign this rate
constant to the dissociation of Ca2+ from the F-
M16N–S100A4–Ca2+ complex (k−3), with subsequent
rapid dissociation of F-M16N via k−0, because theS100A4 concentration (NK2=1.3 μM) would ensure
that the flux through the other route (via k−2 and k−1 in
Scheme 1) would be low (the calculated kobs through
this route: kobs=16×1.3/(1.3+10)=1.8 s
−1). From the
overall thermodynamic balance of Scheme 1, the
estimated rate constants lead to a k3 value of
N5×108 M−1 s−1, which is close to the diffusion-
controlled limit, for Ca2+ binding to the preformed
F-M16N–S100A4 complex. The kinetics of M32
binding, as far as determined, were comparable to
those of F-M16N (see Supplementary Data).
Table 2. Summary of rate and equilibrium constants defined according to Scheme 1
Myosin peptide/
fragment K0 (μM) K1 (μM) k1k1 (μM
−1 s−1) k−1 (s
−1) K2 (μM) k2 (μM
−1 s−1) k−2 (s
−1) K3 (μM) k3 (μM
−1 s−1) k−3 (s
−1)
F-M16N N300 5 3.2 16 1.3 4.9 6.2 b0.02 N500 9.4
M16N ND Above values common
to all targets
N100 ND ND
M32 N100 3 ∼2 ∼6 b0.15 N16 3.2
M200 N100 ∼0.003 ND b0.3 b0.00015 N2000 0.3
ND, not determined.
The limit of K3 was calculated from K3=K1K2/K0.
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S100A4–Ca2+ dissociation kinetics
Ca2+ dissociation measurements for wild-type
S100A4, using Quin-2 as described above, were
repeated as a control for the effect of target peptides
on this process. On mixing 10 μM S100A4 in the
presence of Ca2+ with 100 μM Quin-2, the observed
profile was fitted to a single exponential with
kobs=17 s
−1 (Fig. 5a; cf. k−1 in Scheme 1). The
observed Ca2+ dissociation rate constant from
S100A4 was unaffected by the presence of 50 μM
M16N (i.e., the peptide without fluorescein label)
when premixed with S100A4 (Fig. 5b), whereas the
same concentration of M32 caused the rate constant
to be reduced to 3.3 s−1 (Fig. 5c). This observation
supports the above findings that M32 binds much
more tightly to S100A4 than does M16N. The
concentration dependence of the observed Ca2+
dissociation profile confirmed that M32 bound to
S100A4 with a Kd in the micromolar region (K2;
Scheme 1). When the stopped-flow traces were fitted
to a single exponential, the observed rate constant
kobs as a function of [M32] could be fitted to a
quadratic equation to yield a limiting rate constant
of 3.2 s−1 at saturating [M32], compared with 17 s−1
in the absence of M32 (Fig. S3a). The former
represents the dissociation rate constant of Ca2+
from the M32–S100A4–Ca2+ complex (k−3; Scheme
1). Such an analysis assumes that the M32 binding
kinetics are fast relative to the Ca2+ dissociation
kinetics. The alternative model that can be solved
analytically is that for slow M32 binding. In the
latter case, the stopped-flow traces at intermediate
[M32] would be biphasic, with the relative ampli-
tude of the slow phase (k−3=3.2 s
−1) increasing at
the expense of the fast phase (k−1=17 s
−1) with
increasing [M32]. A comparison of fits to a single
exponential and fits to a biphasic exponential with
fixed rate constants and variable amplitudes (i.e.,
both equations had three free parameters) to the
data obtained at 0.25 μM M32 showed small
deviations in the residuals with similar magnitudes
but opposite signs. This suggests that the kinetics of
Ca2+ and M32 dissociation from the M32–S100A4–
Ca2+ complex are comparable (k−2≈k−3), as might
be expected from the kinetics of competition withF-M16N binding (Supplementary Data). However,
while both fast binding models and slow binding
models are approximations, they yielded similar
values for the apparent Kd for M32 binding
(K2=0.4 μM), which is smaller than that deduced
by the anisotropy competition assay, and also
suggested a stoichiometry closer to 0.5 mol of
M32 per S100A4 monomer than 1:1.
Similar measurements were made to investigate
the dissociation of Ca2+ from S100A4 in the presence
of the coiled-coil fragments M111 and M200,
revealing a slower release of Ca2+ (0.3–0.5 s−1; Fig.
5d; Fig. S3b). When increasing concentrations of
M111 were added to S100A4, the rate constants of
the fast and slow phases remained approximately
constant (20 s−1 and 0.4 s−1), while the amplitudes
interchanged. This is indicative of a slow equilibri-
um between free M111 and bound M111 relative to
the rate constant for Ca2+ release. In the case of
M200, the measurement was complicated by the fact
that, in 100 mM NaCl, this fragment forms
filamentous aggregates (see the text below). How-
ever, on addition of twice the stoichiometric amount
of S100A4 in the presence of Ca2+, the aggregates
were solubilised and the solution had low turbidity.
On mixing with excess Quin-2, free Ca2+ was
rapidly chelated, and the M200–S100A4–Ca2+ com-
plex dissociated. The liberated M200 then formed
filaments. Simultaneous measurement of Quin-2
fluorescence and light scatter showed that the latter
reaction had a substantial lag and that the Ca2+
dissociation phase was essentially complete before
the aggregation phase began (Fig. 5d). Consequent-
ly, there was little optical interference from the
change in light scatter on the measured Ca2+
dissociation kinetics. Furthermore, similar Ca2+
dissociation kinetics were obtained in 200 mM
NaCl, where M200 remains soluble (Fig. S5a).
However, as Quin-2 chelates Ca2+, the increasing
absorbance of Quin-2 gave rise to a small inner filter
effect that initially reduced the observed light scatter
signal. The major phase of the Quin-2 signal had a
rate constant (k−3) of 0.3 s
−1 attributed to Ca2+
dissociation from the M200–S100A4–Ca2+ complex
(Fig. 5d), a value similar to that for the M111
complex. It is likely that once Ca2+ dissociates, the
M200–S100A4 complex also rapidly dissociates
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Fig. 5. Dissociation of Ca2+ from S100A4 in the absence and in the presence of target peptides monitored using Quin-2
fluorescence. (a) Mixed with 100 μM Quin-2 was 10 μM S100A4+50 μM Ca2+ (stopped-flow reaction chamber
concentrations). A superposed fit to a single exponential yields kobs=17 s
−1. (b) As in (a), but with 50 μMM16N premixed
with S100A4 (kobs=16 s
−1). (c) As in (a), but with 50 μMM32 premixed with S100A4 (kobs=3.3 s
−1). (d) As in (a), but with
2.5 μM M200 premixed with 5 μM S100A4. A biphasic exponential fit yielded rate constants of 13 s−1 (A=26%) and
0.30 s−1 (A=74%). The broken line shows increased light scatter at 336 nm as the released M200 formed filaments in the
absence of Ca2+ with a 10-s lag and indicates that this process did not influence the profile of Quin-2 fluorescence.
Experiments were carried out in either 20 mMNaCl, 20 mM Tris, 1 mMDTT, and 100 μMCa2+ at pH 7.5 and 20 °C (a and
b; cf. Malashkevich et al.17), or 100 mM NaCl, 10 mM Hepes, and 100 μM Ca2+ at pH 7.5 and 20 °C (c and d). Similar
profiles were observed for experiments (a and b) performed in the latter buffer and yielded rate constants of 16 s−1,
indicating a weak binding of M16N under both conditions. Rate constants were unaffected by the inclusion of 1 mMMg2+.
1012 S100A4-Myosin IIA Interactions(k−0≫k−3), but the increase in light scatter is not
observed immediately because filament formation
has a slow nucleation event (see the text below). The
slower dissociation of Ca2+ from the M111 and M200
complexes (0.3 s−1), comparedwith the M32 complex
(3.2 s−1) and the F-M16N complex (9.4 s−1), could be a
consequence of the stabilisation of a multimeric
complex due to the coiled-coil nature of the fragments
and/or becausemyosin residues beyond theminimal
binding region identified above (residues 1907–
1938≡M32) are involved (see Discussion).
The binding of Ca2+ and a target peptide to
S100A4, as shown in Scheme 1, is thermodynami-
cally coupled so that K1K2=K0K3. For simplicity, weassume a 1:1 stoichiometry and independent bind-
ing sites, which are unlikely to be true at least for the
longer fragments. However, the trends in binding
remain valid for more complex cases. Binding of
target peptides to S100A4 in the absence of Ca2+ is
weak (K0N100 μM), while binding of target peptides
to S100A4 in the presence of Ca2+ (K2) is around a
micromolar or less for longer fragments. Knowing
that Ca2+ binding to S100A4 has K1=2–5 μM (from
the ITC data above and the literature14,17,18) requires
that Ca2+ binding to the M–S100A4 complex be very
tight (K3b0.15 μM and even lower for M200). The
latter cannot be easily determined directly as it
requires protein concentrations greater than K0
1013S100A4-Myosin IIA Interactions(i.e., NN100 μM) so that the proteins remain bound
together throughout the titration with Ca2+. How-
ever, K3 is readily determined by calculation
because values or limits for K0, K1, and K2 are
available (Table 2). This aspect is addressed further
below for M200, which has the complication of
forming filaments at the ionic strength used.
NMR spectroscopy of peptide complexes
The contributions of different myosin regions to
the interaction with S100A4 were analysed by NMR.
To observe the direct perturbations of protein
resonance on binding, we used truncated Δ10-
S100A4, which lacks 10 C-terminal residues. From
our data18 and reported data,17 these residues in
crystal form bind to the active site of the protein and
can stabilise the tetrameric state at the high protein
concentrations used for NMR studies. However,
these residues are not involved in any contact in the
dimeric form of the protein. The removal of the C-
terminus had a minor effect on the NMR spectra,
with the 1H,15N heteronuclear single-quantum
coherence (HSQC) spectrum exhibiting highly dis-
persed cross-peaks of uniform intensity that corre-
spond to a stable globular fold (Fig. 6). No
interaction was observed for Δ10-S100A4 in the
absence of Ca2+, as expected from the above kinetic
studies. In the presence of Ca2+, the largest
perturbations in the NMR spectra were detected
on the addition of M32 (Fig. 6a). In the course of the
titrations, the majority of resonances displayed
chemical shift changes accompanied by severe
broadening for many signals, leading to a complete
disappearance for some of them (Fig. 6a, inset). At
M32 concentrations above equimolar, the resonance
broadening was gradually reduced; at a Δ10-
S100A4/M32 ratio of 1:3, most of the HSQC cross-
peaks can be detected, although a significant
number of cross-peaks still remained more broad-
ened than the rest. These spectral changes corre-
spond to the intermediate-exchange regime between
the free state and the bound state on Δ10-S100A4.
The exchange rate for M32 binding can be estimated
from the chemical shift difference between the free
state and the bound state for the cross-peak
highlighted in Fig. 6a (inset). This cross-peak
displays extensive broadening accompanying a
progressive chemical shift change characteristic of
the intermediate exchange, with the chemical shift
difference (rad s−1) comparable to the exchange rate
constant kex = kon+ koff. The shift difference of
0.12 ppm at 600 MHz gives the exchange rate
constant estimate of kex∼450 s−1 at 35 °C, in fair
agreement with the k2[S100A4]+k−2 value deter-
mined by stopped-flow analysis at 20 °C in Table 2.
A similar intermediate-exchange regime had been
previously characterised for the binding of S100A11
to its target annexin A2.28In contrast, the titration ofΔ10-S100A4 with either
M16N or M15C demonstrated fast exchange between
the free state and the bound state (Fig. 6b and c,
insets). In both cases, no significant broadening was
detected at the intermediate peptide concentrations,
and the range of chemical shift changes at equivalent
peptide concentrations was much smaller than for
M32. The chemical shift changes on the addition of
M16N were similar to the reported effect of the
corresponding peptide17 and were larger than on
the addition of M15C. The lower range of chemical
shift changes and the faster exchange between the
free state and the bound state for M16N and M15C,
in comparison to M32, demonstrate that neither of
the smaller peptides possesses the binding affinity of
the longer M32 fragment. While the addition of
M16N affects more resonances and the range of
chemical shift changes is larger than for M15C, the
latter contributes significantly to the binding, as
evidenced by the specific chemical shift changes and
the increase of affinity for M32 that span both
regions. The affinities of M16N and M15C were too
low to be measured by NMR, as the binding site was
far from saturation even at a 9-fold molar excess of
the peptides at 0.2 mM Δ10-S100A4.
The involvement of the region corresponding to
M15C can be directly detected by NMR using larger
recombinant myosin fragments. We used full-length
S100A4 for this analysis because the effect of the C-
terminus on the interaction with this tight-binding
myosin fragment was negligible. The 1H,15N HSQC
spectrum of M111 (residues 1850–1960; Fig. 1)
shows a number of sharp intense peaks (Fig. 7).
The majority of the sharp resonances correspond to
the C-terminal region 1926–1960 at the end of the
coiled-coil, agreeing with the prediction that this
region is unstructured and highly dynamic. The rest
of the sharp signals were assigned to the N-terminal
1850–1866 region, demonstrating that it is also
unstructured. No resonances corresponding to the
coiled-coil region 1866–1925 were detected in the
triple-resonance experiments, although a number of
low-intensity broad cross-peaks are present in the
1H,15NHSQC spectra in addition to the signals from
the unstructured parts of the protein. The formation
of coiled coil in the 1866–1925 region results in a
highly elongated structure with a slow rotational
diffusion rate, leading to relaxation broadening of
the NMR resonances. This correlates with the
experimental NMR observation showing that the
M111 fragment is long enough to form a stable
coiled-coil structure. The formation of the coiled coil
correlates with the high helical content detected for
the fragment by CD below 20 °C (Fig. S4b) and
electron microscopy (see the text below).
The addition of full-length S100A4 leads to the
additional broadening of resonances in the 1926–
1939 region and chemical shift changes for the
resonances corresponding to G1940 and D1941
Fig. 6. Chemical shift changes in the 600-MHz 1H,15N HSQC spectra of 0.2 mM 15N-labelled Δ10-S100A4 on addition of
myosin peptides at 35 °C. (a) Superposition of the spectra in free form (black) and in the presence of a 3-fold molar excess of
M32 (red). The inset shows progressive changes in the spectra on peptide addition (intermediate exchange) corresponding to
the followingprotein/peptidemolar ratios (left to right): free (black), 1:0.25 (green), 1:0.5 (light blue), 1:1.5 (dark blue), and 1:3
(red). Cross-peaks corresponding to 1:0.75 and 1:1 molar ratios are too broad to be observed. (b) Superposition of the spectra
in free form (black) and in the presence of a 4-fold molar excess of M16N (red). The inset shows progressive changes in the
spectra on peptide addition (fast exchange) corresponding to the following protein/peptide molar ratios (left to right): free
(black), 1:1 (magenta), 1:2 (light blue), and 1:4 1:3 (red). (c) Superposition of the spectra in free form (black) and in the presence
of a 4-foldmolar excess ofM15C (red). The inset shows progressive changes in the spectra on peptide addition (fast exchange)
corresponding to the following protein/peptidemolar ratios (left to right): free (black), 1:1 (magenta), 1:2 (light blue), and 1:4
1:3 (red).
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Fig. 7. Chemical shift changes in the 1H,15N HSQC spectra of 13C,15N-labelled M111 on addition of full-length S100A4.
Superposition of the spectra in free form (black) and in the presence of a 1.5 molar excess of S100A4 (red). Resonance
assignments derived from the analysis of triple-resonance spectra are marked. In addition to sharp intense cross-peaks,
the spectra contain broad low-intensity peaks that cannot be assigned due to low sensitivity.
1015S100A4-Myosin IIA Interactions(Fig. 7), while the resonances corresponding to the
1942–1960 region are unaffected. The selective
broadening of myosin resonances demonstrates
that the 1926–1939 fragment is immobilised in the
complex and is involved in a direct interaction with
S100A4. This fully correlates with the enhanced
binding of theM32 fragment, compared to the M16Npeptide, and the chemical shift perturbations of the
S100A4 resonances on addition of the M15C peptide
that incorporates the 1926–1939 region. In agreement
with the stopped-flow experiments, the NMR
data show that the 1926–1939 fragment provides
an essential contribution to the S100A4–myosin
interaction.
1016 S100A4-Myosin IIA InteractionsElectron microscopy
Rotary shadowed images of M200 and M111
deposited from high-ionic-strength solutions (0.5 M
ammonium acetate) confirmed that these myosin
fragments formed coiled-coil structures (Fig. 8a and
b). The mean length of M200 was 26.4±2.03 nm
(mean±SD; n=132), consistent with about 170
residues forming a stable coiled coil and 30 residues
comprising the nonhelical C terminus, which wereFig. 8. Characterisation of myosin IIA coiled-coil tail fragme
(b) M111 deposited from 0.5 M ammonium acetate. Scale ba
negatively stained M200 tail fragment. Fields of M200 (c) in the
S100A4, respectively. Arrows point to individual strands em
were prepared in 0.1 M sodium acetate buffer, where M200 fo
the presence of S100A4. Scale bar represents 200 nm (see Matnot visualised by electron microscopy (Fig. S4a).
Using a value of 0.1485 nm per residue for a coiled
coil29 yields an expected length of 25.2 nm. The
M111 preparation appeared more heterogeneous,
probably because the helical structure is only
marginally stable at 20 °C, as determined by circular
dichroism (Fig. S4b).
In 0.1 M Na-acetate, M200 formed filamentous
bundles (Fig. 8c) that were almost 100 nm wide and
several micrometers long. Seen within the structuresnts. Metal-shadowed electron micrographs of (a) M200 and
r represents 50 nm. (c and d) Electron micrographs of a
absence and (d) in the presence of a 2-fold molar excess of
erging from images of filamentous bundles. The samples
rmed large filamentous aggregates but were solubilised in
erials and Methods for details).
1017S100A4-Myosin IIA Interactionsare individual strands about 10 nm wide (Fig. 8c,
arrows), a width comparable to that formed by
intact NM-MHC IIA.30 From the dimensions of
the individual M200 coiled-coil structures
(26 nm×2 nm), it is evident that the aggregates
may contain in excess of 10,000 molecules; in this
respect, they are poor models of the native non-
muscle myosin IIA filament (400 nm long and
containing 28 molecules30). However, the relatively
open structure of the filament bundle allows their
rapid solubilisation on addition of S100A4. On
addition of a two times stoichiometric concentration
(i.e., 2× S100A4 dimer per M200 coiled-coil frag-
ment) in the presence of Ca2+, no trace of filamen-
tous bundles was observed (Fig. 8d). These results
were observed both when the soluble M200 sample
was diluted into a 0.1 M Na-acetate solution
containing S100A4 and when S100A4 was added
to preformed M200 filaments and incubated for
15 min.
Kinetics of M200 filament formation and
solubilisation
M200 filament formation is also evident from the
increased turbidity of the solution, measured as an
apparent absorbance at 300 nm. The turbidity shows
a sharp transition between 100 mM and 200 mM
NaCl, with a midpoint value of about 120 mM NaCl
when 5 μM M200 was used (Fig. S5a). Over the
range of 0–1 absorbance, the turbidity of M200 in
100 mM NaCl buffer was practically linear with
concentration (Fig. S5b). The small offset on the
x-axis indicated a critical concentration of ∼0.1±
0.04 μM M200 at this ionic strength. The value is
difficult to determine accurately from this experi-
ment, but it is clear that if M200 shows a well-
defined critical concentration, then its value
is b0.2 μM. If a line is fitted just to the data obtained
at [M200] between 2.5 μM and 5 μM, the intercept is
0.49 μM, indicating there is a slight upswing in the
turbidity with concentration. It is possible that, at
these concentrations, the turbidity increases more
due to aggregation of existing smaller filaments.
Turbidity assays provide a convenient way to
monitor the kinetics of filament solubilisation by
S100A4.31 We found that a 2-fold molar excess of
S100A4 monomer per M200 polypeptide chain was
required to fully solubilise the M200 filament
aggregate in the presence of Ca2+ (Fig. 9a and b).
Addition of excess EGTA reversed the process,
allowing M200 filaments to reform, while addition
of further Ca2+ caused resolubilisation (Fig. 9a). Both
filament assembly and disassembly appeared at least
biphasic processes, with the first phase being
resolvable just by manual mixing. Stopped-flow
studies confirmed that the reactions did indeed occur
on the seconds timescale and that manual mixing
was sufficient to record most of the profilessatisfactorily (Fig. S6a and b). However, on removal
of Ca2+ with EGTA, there was a lag of a few seconds
before M200 filament formation (Fig. S6b) (as was
noted abovewhenQuin-2was used as chelator) (Fig.
5d), which was not resolved in manual mixing
assays.
The kinetics of the polymerisation and depoly-
merisation of M200 are likely to be complex, as
M200 monomers could add to the ends or the sides
of filaments, and the filaments themselves may
bundle, fragment, or anneal. For the purposes of
discussion, we will consider the dissociation of one
M200 monomer (M) from a filament bundle
(denoted Mn), as shown in Scheme 2.
It is of interest to know whether S100A4 drives
depolymerisation solely by binding to free M
monomer and allowing the polymer equilibrium to
readjust (i.e., via k−4 and k5), or whether S100A4 also
binds to the filament bundle and actively depoly-
merises an M200 unit (via k6 and k−7). It is known
that S100A4 can bind to myosin rod fragments,8,17
but this in itself does not prove that there is
significant flux via k−7. In an attempt to address
this question, the dissociation rate of the M200
filament was followed on jumping the NaCl
concentration from 100 mM to 120 mM in the
absence and in the presence of S100A4 (Fig. 9c).
Under these conditions in the absence of S100A4,
turbidity dropped to about 50% of its initial value
with a profile fitted to a double exponential
(k1obs = 0.33 s
− 1 with 12% amplitude and
k2obs=0.037 s
−1 with 43% amplitude, relative to the
total amplitude expected for a full dissociation).
Therefore, at the end point of this reaction, the
filament concentration decreased by about 2-fold
(turbidity is proportional to concentration over this
range; Fig. S5b). There should also be a
corresponding rise in M200monomer concentration,
but this may be less than accounted for by the loss of
filaments if the drop in turbidity was also associated
with a rise in small M200 oligomers with a lower
specific turbidity. The underlying kinetics for this
reaction is complex, with the exponential-like
character having possible contributions from: (i)
the depletion of the initial filament concentration
(i.e., a first-order-like reaction) and a buildup of
monomers and small oligomers that could repoly-
merise; (ii) zero-order kinetics (i.e., linear) for
dissociation restricted to filament ends but with
length-dependent dissociation rate constants (i.e.,
progressively smaller rate constants as the filament
shortens), as proposed for synthetic skeletal myosin
filaments;32 or (iii) a nonlinear relationship between
specific turbidity and filament size10 so that the
initial fragmentation of larger filaments contributes
to more signal change than the disassembly of small
oligomers at the latter stages of the reaction. The
practically linear relationship observed in Fig. S5b
argues that (iii) is unlikely to be the dominant
(a)
0
0.4
0.8
1.2
0 400 800 1200 1600
Tu
rb
id
ity
 (A
30
0 
cm
-
1 )
Tu
rb
id
ity
 (A
30
0 
cm
-
1 )
Tu
rb
id
ity
 (A
30
0 
cm
-
1 )
Time (s)
i  ii     iii  iv
+M32
+M16N
(b) (c)
0
0.5
1
1.5
0 100 200 300 400 500 600
Time (s) Time (s)
i ii iii
0
0.1
0.2
0.3
0.4
0 25 50 75 100
Fig. 9. Dissociation of M200 filaments by S100A4. (a) Initially, M200 was added (i) from a concentrated stock in 0.5 M
NaCl to give a final concentration of 5 μMM200 (with respect to the polypeptide chain) in 100 mM NaCl, 10 mM Hepes,
and 0.1 mM Ca2+ at pH 7.5 and 20 °C. A biphasic rise in turbidity was recorded for 200 s (continuous line). Then 10 μM
S100A4 (with respect to monomer concentration) was added (ii), followed by 0.2 mM EGTA (iii) and 1 mM Ca2+ (iv). The
experiment was repeated in the presence of 250 μMM32 (broken line) or 250 μMM16N (dotted line). (b) M200 was diluted
(i) into 100 mM NaCl to form filaments as in (a), then 5 μM S100A4 was added (ii), causing a 54% drop in turbidity. A
further 5 μM S100A4 (iii) caused turbidity to fall to almost zero. (c) Stopped-flow records monitoring the dissociation of
5 μM M200 filaments on jumping [NaCl] from 100 mM to 120 mM NaCl. Other components of the buffer were 20 mM
Hepes, 1 mMMg2+, and 100 μMCa2+ at pH 7.5 and 20 °C. The upper trace, obtained in the absence of S100A4, showed a
45% decrease in turbidity with rate constants of 0.33 s−1 (22% amplitude) and 0.037 s−1 (78% amplitude). In the presence
of 20 μM S100A4 (lower trace), the turbidity decreased by 87% with a rate constant of 0.2 s−1. The broken line shows the
calculated profile when the disassembly of the M200 filaments occurred only by sequestration of monomeric M200
by S100A4 with a rate constant of 0.04 s−1, which gives the same initial rate as observed in the absence of S100A4
(see the text).
Scheme 2. M200 filament (Mn) dissociation by S100A4.
1018 S100A4-Myosin IIA Interactionscontribution. However, regardless of the detailed
mechanism, if S100A4 dissociated M200 filaments
simply by sequestering the free M200 monomers,
then it is likely that the initial rate of the depolymer-
isation reaction, when monomer reassociation is
negligible, would be unaffected by S100A4 and that
only the amplitude would change. This can be
modelled empirically with an exponential function
having a 100% amplitude and a rate constant of
0.04 s−1 (Fig. 9c, broken line) to give the same initial
rate as a reversible reaction with a 12% amplitude
and an observed rate constant of 0.33 s−1 (i.e.,
modelling kobs=koff+kon and amplitude=100×koff/
1019S100A4-Myosin IIA Interactions(koff+kon)%). In the presence of 20 μM S100A4 (the
concentration after the NaCl jump), the reaction had
almost double the amplitude (indicating near-full
dissociation of the M200 filament) and was closer to
a single exponential (kobs=0.19 s
−1; a biphasic fit
yielded a 85% amplitude with kobs=0.21 s
− 1).
Significantly, the initial rate (i.e., slope) was five
times faster than in the absence of S100A4 (Fig. 9c).
This indicates that S100A4 bound to the M200
filament aggregate and caused an enhanced rate of
monomer dissociation. A similar conclusion was
reached from measurements made for a 2-fold
dilution at 100 mM NaCl (data not shown).
However, here, the turbidity change on dilution in
the absence of S100A4 was only 10% of the
amplitude obtained in the presence of S100A4;
thus, the kinetics of the former were dominated by
the association rate constant.
Further information on Scheme 2 was obtained
from competition assays. In the presence of M32, the
solubilisation of M200 was incomplete owing to
competition for the S100A4; however, relatively
high concentrations of M32 were needed to give a
detectable effect (Fig. 9a, broken line). In the
presence of 5 μM M200, 250 μM M32 was required
to give a 50% inhibition in the amplitude of turbidity
change. These data yield an estimate of
K5≈0.001 μM, which represents the binding of
S100A4–Ca2+ to free M200. An independent esti-
mate of K5 based on the Ca
2+ dependence of the
turbidity assay yielded a value of 0.003 μM (see
Supplementary Data). Thus, monomeric M200 (i.e.,
coiled-coil dimer) binds 3 orders of magnitude
tighter than M32 to S100A4. The presence of
250 μM M16N had no effect on the amplitude of
the turbidity changes in M200 (Fig. 9a, dotted line),
confirming that it binds more than an order of
magnitude weaker to S100A4 than M32.
Knowledge of the equilibrium and rate constants
for Ca2+ binding to free S100A4 and target complexes
is of value in estimating the degree of interaction of
these proteins in cells, where the resting cytoplasmic
[Ca2+] is around 0.1 μM and rises transiently to 1–
10 μM on excitation. Using the rate and equilibrium
constants determined for M200 (Scheme 1, Table 2)
and a simplified model for filament formation (see
Supplementary Data), we calculated the time courses
for a single Ca2+ pulse (Fig. 10a) and a step increase in
free Ca2+ (Fig. 10b). As expected from the data in Fig.
S6c, at the initial resting Ca2+ of 0.1 μM, there is
significant interaction between S100A4 and myosin
when both are present at 2 μM concentration, such
that 40% of the total myosin is present as the soluble
M–S100A4–Ca2+ complex (Fig. 10a, blue line). In the
absence of S100A4, only 6%of themyosin is present in
monomeric form (the parameters for filament forma-
tion were chosen to give a free myosin concentration
close to the estimated critical concentration of 0.1 μM).
However, a brief Ca2+ pulse has little further effect onthe concentration of filamentous myosin, as its
kinetics are too slow to respond (Fig. 10a, black
line). On the other hand, S100A4 does interact with
Ca2+ on this timescale, but the concentration of
S100A4–Ca2+ (Fig. 10a, red line) remains small
owing to its relatively weak binding (modelled with
Kd=4 μM). For a significant decrease in the concen-
tration of myosin filaments (Fig. 10b, continuous
black line), the Ca2+ concentration needs to remain
above 1 μM for tens of seconds. A train of pulses over
this timescale would also be effective in partially
dissociating the myosin filaments to an extent
dependent on the average Ca2+ concentration (Fig.
S7).
The above modelling assumes that the kinetics of
M200 filament disassembly measured in vitro (Fig.
9c) occurs on a timescale similar to that of myosin
filaments in vivo. To test for this, we performed
fluorescence recovery after photobleaching (FRAP)
measurements on A431 cells expressing green
fluorescent protein (GFP)–myosin IIA (Fig. 10c). In
the absence of activating transcription factors, these
cells do not express significant amounts of S100A4
and in the absence of epidermal growth factor, the
mean cytoplasmic [Ca2+] is close to resting levels.
The cells were immobilised on Y-shaped fibronectin
patterns to give a reproducible arrangement of stress
fibres spanning the apices of the cell.33 Photobleach-
ing recovery occurred over a 3-μm diameter with a
time constant of around 20 s (Fig. 10d). While
analysis of FRAP kinetics is complex, it appears to be
dominated by the dissociation rate constant of GFP–
myosin from the stress fibre, rather than diffusion, as
the stress fibre intensity recovered with practically
the same time course along its 3-μm length.34
Furthermore, monomeric myosin in the cytoplasm
would be expected to diffuse across the 3-μm
diameter within a few seconds. These studies
confirm that for a Ca2+-dependent control of myosin
filament dissociation via a calcium-binding protein
such as S100A4, the mean free [Ca2+] would need to
remain elevated for tens to hundreds of seconds.
However, even at resting levels of Ca2+, S100A4
expressed at micromolar levels in the cytoplasm
should be effective in dissociating myosin filaments.Discussion
In this article, we reexamine aspects of Ca2+ and
NM-MHC IIA tail fragment binding to S100A4 and
extend the study through new kinetic measure-
ments. Ca2+ binds to the S100A4 dimer with an
affinity of around 2–6 μM. ITC measurements
indicate a stoichiometry of one Ca2+ per S100A4
monomer and a Kd of 1.7 μM,with a second site with
Kd=6 μM revealed at temperatures of ≥30 °C.
Regarding the assignment of the sites to EF1 or EF2,
the E33Q mutant appears more similar to wild-type
Fig. 10. (a) Simulated response of the kinetic pathway (Scheme 1) to a single wave of Ca2+ (broken line) with a rise time
constant of 10 ms and a decay constant of 100 ms. For simplicity, the myosin filament was modelled as a cooperative
system 5M↔M5 (see Fig. S7 for further details). The total concentrations of the components were 2 μM S100A4 and 2 μM
myosin (monomer concentration). Filament (black line), S100A4–Ca2+ (red line), andM–S100A4–Ca2+ (blue line). (b) As in
(a), but with the response to a step increase in free Ca2+ to 2 μM. (c) FRAP of GFP–myosin IIA expressed in an A431/SIP1
cell immobilised on a Y-fibronectin pattern (CYTOO Chip™). The TIRF image is derived from a sequence 1 s after the
bleaching of a 3-μm-diameter spot (broken circle) across a stress fibre. Scale bar represents 10 μm. (d) FRAP time course of
the bleached spot in (c), normalised against an unbleached region of the filament, to yield a recovery rate constant of
0.046 s−1.
1020 S100A4-Myosin IIA InteractionsS100A4 than the D63Nmutant and has an intact EF2
site, as determined by tyrosine and Quin-2 fluores-
cence (Fig. 3a; Fig. S1b). The weaker binding site of
native S100A4 seen by ITC (Fig. 2a) would then
correspond to EF1, as assumed by Malashkevich et
al.17 The resolved Quin-2 signal therefore reflects
Ca2+ that was bound to EF2, with Ca2+ release from
EF1 being too fast to measure. In the presence of
target peptides, the amplitude of the Quin-2 signals
increases by no more than 20%, suggesting that the
release of any Ca2+ bound to EF1 remains too fast to
measure. The small increase in amplitude of theresolved phase could reflect the increase in the initial
degree of binding to EF2 at a fixed free [Ca2+], in line
with the decrease in Kd for Ca
2+. Previously, we
reported a stoichiometry of binding of 1.7±0.18
Ca2+ bound per S100A4 monomer, based on the
amplitude of the tyrosine fluorescence change on
addition of Ca2+.18 These signals were much noisier
than those recorded using the Quin-2 indicator
reported here. Furthermore, the calculated stoichi-
ometry is critically dependent on the accuracy of the
S100A4 concentration determination. S100A4 lacks
tryptophan, and the absorbance from the two
1021S100A4-Myosin IIA Interactionstyrosine residues is weak, so the conclusions are
dependent on the accurate correction for turbidity
and the lack of significant UV-absorbing contami-
nants. However, the unchanged amplitude of the
Quin-2 signal on Ca2+ dissociation from the wild
type compared with the E33Q mutant (Fig. 3a)
argues strongly that a single site (EF2) per monomer
is involved. Nevertheless, there is communication
between the EF1 domain and the EF2 domain on
dissociation of Ca2+ from EF2, as indicated by
tyrosine fluorescence (Fig. S1c), which could account
for the NMR findings of Dutta et al., who concluded
that EF1 had a higher affinity.15
We confirm that a 16-amino-acid myosin peptide
derivative, F-M16N, binds to S100A4 in the presence
of Ca2+ with an affinity of around 1 μM,17 but we
consider the fluorescein moiety to make a large
contribution to the binding energy because the
corresponding unlabelled M16N peptide binds
2 orders of magnitude more weakly. The data of
Malashkevich et al. imply that the unlabelled M16N
peptide binds almost as tightly as longer fragments,
although no raw data are shown for this peptide.17
In our analysis (Fig. 4b), M32 and F-M16N were
assumed to bind to each monomer independently.
However, the stoichiometry of M32 binding (Fig.
S3a) suggests that one M32 peptide may span two
monomers of S100A4, so it could compete with two
molecules of F-M16N. Fitting to such a model yields
a Kd of 1.5 μM for the M32 peptide (i.e., half that of
the simple model). From our measurements, a
32-mer peptide (corresponding to A1907-G1938 of
the myosin sequence) represents a minimal binding
region. Longer fragments (M111 and M200) bind
with even higher affinity, indicating that additional
amino acids of the myosin heavy chain contribute to
the binding interaction and/or the capacity of the
longer fragments to form coiled-coil structures
enables higher-order structures to form with
increased avidity. We are currently exploring longer
peptides to address this question and consider that
both factors are involved.
Based on the S100A4 concentration determined
from the absorbance at 280 nm, one mol of M32
peptide binds to two S100A4 monomers. In support
of this conclusion, the ITC titration curve of an
R1893-R1923 myosin fragment of Malashkevich et
al. (their Fig. 1117) shows a stoichiometry close to
0.5 mol of peptide per mole of S100A4 (dimer), in
which concentrations of the components were
determined from quantitative amino acid analysis.
The site between helix III and helix IV of S100A4,
exposed in the presence of Ca2+, could accommo-
date an α-helical target of about 16 residues. The
longer M32 minimal peptide identified above
suggests that the myosin binding site may extend
beyond a single S100A4 monomer, as was reported
for the novel interactions of a 31-mer SIP (Siah-
interacting protein) fragment with the S100A6dimer, as determined by NMR.35 The conclusion
regarding the S100A4: peptide target stoichiometry
reported here requires confirmation by comparable
structural methods.
A corresponding stoichiometry is also seen in the
interaction of S100A4 with M200, where 2 mol of
S100A4monomer was required to solubilise 1 mol of
M200 aggregate (when expressed as M200 polypep-
tide chain concentration) (Fig. 9b). Murakami et al.31
found that a S100A4/M200 ratio of 5:1 was required
for solubilisation in their assays, whereas Li et al.11
found that 1 mol of S100A4 dimer was required to
disassemble 1 mol of NM-MHC IIA rods. These
stoichiometries complicate the calculation of the
equilibrium parameters for the models described in
Schemes 1 and 2. If the binding sites remained
independent, then Kd values would be altered by
just a statistical factor but would more likely extend
the potential for cooperativity. However, until
accurate stoichiometries are determined by direct
structural methods, Schemes 1 and 2 provide a
useful start point for the discussion of thermody-
namic coupling. As a consequence of this coupling
in Scheme 1, the very weak binding of target
proteins to S100A4 in the absence of Ca2+ requires
the target-bound form of S100A4 to bind Ca2+ with a
very high affinity (Table 2). In the case of bound F-
M16N, the estimated Kd limit for Ca
2+ binding is
b20 nM. It is important to stress that this would not
be the observed Kd for Ca
2+ binding to a mixture of
F-M16N and S100A4, unless the peptide concentra-
tion was much greater than millimolar (i.e.,
exceeded K0 in Scheme 1), because the observed
constant would reflect both the binding of peptide to
S100A4 and the binding of Ca2+ to this complex. A
similar argument applies to M200, but here the
thermodynamic coupling factor appears even greater
(possibly because of avidity due to the two potential
binding sites from each chain of the coiled coil of
M200). The physiological consequence of this is that
the myosin tail and S100A4 could bind at resting
cytoplasmic Ca2+ levels and cause filament disas-
sembly, provided at least one of the protein
components is present at a concentration exceeding
several micromolars (cf. Fig. S6c). Unfortunately,
there are no reliable estimates of the effective
concentrations of S100A4 in cells, although total
concentrations of micromolar might be expected.22
Cell excitation that leads to elevated [Ca2+] would
promote further myosin filament disassembly.
However, the modelling shown in Fig. 10 indicates
that a sustained rise in [Ca2+] lasting tens of seconds
is required in order to achieve a significant effect.
In the absence of added Ca2+ (i.e., where the free
“contaminant” [Ca2+] in buffers would be of the
order of 1 μM), mixing S100A4 with excess Quin-2
produced a small-amplitude signal (corresponding
to 0.1 mol of Ca2+ per mole of S100A4 monomer)
with a rate constant of around 1 s−1. This is similar
1022 S100A4-Myosin IIA Interactionsto the rate constants obtained for target-bound
S100A4 and suggests that this process might
correspond to the dissociation of Ca2+ from a small
fraction of the S100A4 tetramers. The crystal
structure of the Ca2+-bound form of the S100A4
tetramer shows that the C termini of two of the
monomers are positioned in the target binding sites
of two opposing subunits.18 Indeed, in this article,
we drew attention to the C-terminal sequence
ExFPxxxP, which is similar to the DLPFVVP
sequence identified within the minimal myosin
target peptide (Fig. 1). An S100A4 construct lacking
the last 13 C-terminal residues fails to from higher
oligomers beyond the dimer.17 The tetramer and
higher oligomers of the wild type are therefore
unlikely to bind to the myosin target site with
significant affinity because of the competition with
the C-terminus. Based on thermodynamic coupling,
the tetramer would also be expected to have a higher
affinity for Ca2+ than for the dimer. Indeed,
ultracentrifuge data17 suggest that the affinity
would be about 20-fold higher. A Ca2+ Kd value of
around 0.1 μM for the tetramer would suggest
that overexpression of S100A4 could lead to
oligomerisation of S100A4 at resting cytoplasmic
[Ca2+]. In addition, phenothiazine drugs have
been reported to induce S100A4 oligomers and
to inhibit interaction with NM-MHC IIA.36 It is
possible that there are natural effectors that
operate by this mechanism.
S100A4 solubilises M200 filament aggregates in
the presence of Ca2+; in terms of kinetics, this
construct serves as a model system for studying
the mechanism of depolymerisation of intact NM-
MHC IIA filaments. S100A4 binds to M200
filament aggregates and actively depolymerises
them, rather than just binding to the monomer and
perturbing the myosin filament equilibrium. How-
ever, the (M200)n.S100A4.Ca
2+ filament complex is
only a transient species that leads to a solubilised
M200.S100A4.Ca2+ complex. This has implications
for in vivo studies, since the degree of colocalisation
of S100A4 with myosin filaments may be rather
limited under steady-state conditions, and any
solubilisation would lead to a more general cyto-
plasmic distribution of both proteins. Zhang et al.
found that an eCFP-S100A4 construct did interact
with a NM-MHC IIA–eYFP rod construct in the
cytoplasm of HeLa cells, using fluorescence lifetime
imaging.37 As these experiments required 5 min of
acquisition time, the time-averaged Ca2+ concentra-
tion was likely to be close to resting levels and thus
corroborates the potential for these proteins to
interact at Ca2+ concentrations significantly lower
than the Kd for S100A4 in the absence of target.
However, the in vivo case is complicated by further
regulatory mechanisms such as myosin
phosphorylation38 and cross-reactivity between
other S100 proteins and their targets.Materials and Methods
Peptides and proteins
M32, M16N, and M15C peptides (Fig. 1) with an
acetylated N-terminus and an amidated C-terminus at
95% purity were purchased from Peptide 2.0, Inc.
(Chantilly, VA). The composition of the peptides was
confirmed by mass spectroscopy, and the sequence of the
M16N fragment was also confirmed by tandem mass
spectrometry fragmentation and cyanogen bromide cleav-
age. F-M16N, a fluorescein derivative linked to M16N via
an aminohexanoic acid linker, was obtained from Biosyn-
thesis, Inc. (Lewisville, TX) and was identical with FITC-
MIIA1908–1923 as used by Malashkevich et al.17
The mutant forms of S100A4 were made using the
QuikChange Site-Directed Mutagenesis kit (Stratagene)
and the following oligonucleotides:
5′ CCACCTTCCACAAGTTCTCGGGCAAAGAGG 3′
and 5′ CCTCTTTGCCCGAGAACTTGTGGAAGGTGG
3′ for Y19F S100A4;
5′ GGACTTCCAAGAGTTCTGTGTCTTCCTGTC 3′
and 5′GACAGGAAGACACAGAACTCTTGGAAGTCC
3′ for Y75F S100A4;
5′ GCTCAACAAGTCACAGCTAAAGGAGCTGC 3′
and 5′ GCAGCTCCTTTAGCTGTGACTTGTTGAGC 3′
for E33Q S100A4; and
5′ GATGAGCAACTTGAACAGCAACAGGGAC 3′
and 5′ GTCCCTGTTGCTGTTCAAGTTGCTCATC 3′ for
D63NS100A4. To check that no spurious changes had arisen
as a result of the mutagenesis reactions, we resequenced the
entire S100A4 gene in each mutant construct.
Recombinant wild-type and mutant forms of S100A4
were expressed andpurified fromEscherichia coliBL21(DE3)
cells. Transformed cellswere grown overnight at 37 °C in 2×
YT media supplemented with 100 μg mL−1 ampicillin. The
overnight culture (15mL)was used to inoculate 1 L of 2×YT
media containing 100μgmL−1 ampicillin. The cultureswere
grown at 37 °C until the OD600 had reached a value of∼0.8,
and then isopropyl 1-thio-β-D-galactopyranoside (to a final
concentration of 0.25mM)was added. The temperaturewas
reduced to 30 °C, and incubation continued overnight. Cells
were harvested by centrifugation (20 min, 6000 rpm, 4 °C),
and cell pellets were resuspended in lysis buffer [50 mM
NaH2PO4, 300 mM NaCl, and 10 mM imidazole (pH 8.0)]
supplemented with two Complete Protease Inhibitor
Tablets (Roche). Cells were lysed by sonication (6×30 s
pulses with 30-s intervals using an MSE Soniprep 150
sonicator). After sonication, DNase I and MgCl2 (to a final
concentration of 20 mM) were added, and the suspension
was stirred for 30 min at 4 °C. The lysate was centrifuged at
18,000 rpm for 50 min, and the cell-free extract was loaded
onto a 20-mL column of Ni-NTA Superflow resin (Qiagen)
equilibrated in lysis buffer. The resin was washed with
400 mL of wash buffer [50 mM NaH2PO4, 300 mM NaCl,
and 20 mM imidazole (pH 8.0)], and the protein was eluted
using a linear gradient ranging from 20 mM to 250 mM
imidazole in 50 mMNaH2PO4 and 300 mMNaCl (pH 8.0).
S100A4-containing fractions were pooled and concentrated
using a centrifugal 3000 molecular weight cutoff filter unit
(Millipore). The protein was further purified using a
Superdex 75 gel-filtration column equilibrated in 10 mM
Hepes, 20 mM NaCl, and 2 mM DTT (pH 7.5) buffer. Pure
S100A4-containing fractions eluted from the column were
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purification of M111 and M200 were similar to those for
S100A4, except that the buffer used for the Ni-NTA column
contained 500mMNaCl forM200 and the final gel-filtration
column (and subsequent protein storage) contained100mM
NaCl (for M111) or 500 mM NaCl (for M200), respectively,
and lacked DTT. Uniformly 15N-labelled S100A4 was
expressed in 2×M9minimal medium using 4 g L−1 glucose
and 1 g L−1 15NH4Cl. Uniformly
15C,15N-labelledM111was
expressed in 2× M9 minimal medium using 2 g L−1 [13C]
glucose and 1 g L−1 15NH4Cl. Labelled proteins were
purified following the same protocols as for unlabelled
proteins.
Isothermal titration calorimetry
ITC data were collected using a VP-ITC microcalorim-
eter (MicroCal Ltd., Northampton, MA) and analysed by
fitting to a single-site binding equation or a two-site
binding equation using MicroCal Origin software.
Absorption and turbidity measurements
Absorption spectra were recorded using a Cary 50
spectrophotometer (Varian Ltd., Walton on Thames, UK).
Protein concentrations were calculated from their absor-
bance at 280 nm, using molar coefficients of 2980 M−1 cm−1
(M200 and S100A4) and 1490 M−1 cm−1 (M111), based on
their tyrosine content (two residues per chain and one
residue per chain, respectively). Myosin fragments were
measured in 0.5 M NaCl buffer, and care was taken to
correct for the small contribution from turbidity. Protein
concentrations are stated in terms of their monomeric
polypeptide chain concentration.Under the conditions used
for kinetic analysis, S100A4 is predominantly a dimer,21,25
and M200 and M111 form stable coiled coils; therefore, the
molar protein concentrations are half those given in all three
cases. Fluorescence emission spectrawere also checked, and
those preparations containing a detectable shoulder at
340 nm due to contaminating tryptophan-containing
proteins were subjected to further purification. F-M16N
concentrations were based on fluorescein absorbance
(ɛ490=78,000 M
−1 cm−1). Other peptide concentrations
(M32 and M16: N95% purity) were based on their dry
weight concentration. Quin-2 concentrations were calculated
from ɛ354=5000 M
−1 cm−1 in the absence of Ca2+.39
Turbidity assays used to monitor M200 filament formation
and solubilisation with manual mixing were carried out
using a 10-mm pathlength and a 0.1-ml microcuvette
(105.250-QS; Hellma, Southend on Sea, UK) at a wavelength
of 300 nm. For determination of the free Ca2+ concentration,
Fura-2 fluorescence excitation spectra were measured in the
same cuvette using the 2-mm path for excitation to minimise
inner filter effects.
CD spectra were measured on a JASCO J-715 spectro-
polarimeter equipped with a JASCO PTC-348WI temper-
ature-controlled unit at 0.05 mM protein solutions using a
1-mm pathlength microcuvette.
Fluorescence spectroscopy
Fluorescence spectra and anisotropy measurements
were recorded using an SLM 8000 spectrofluorimeter(SLM, Urbana, IL). Fluorescein anisotropy measurements
were carried out in L-format using a 515-nm emission
filter. The four combinations of vertical and horizontal
polarisers (vv, vh, hh, and hv) were each recorded for 30 s,
and then the initial setting (vv) was re-read to check for
signal stability. Calculations of the total fluorescence
(Ivv+2Ivh) and anisotropy (Ivv− Ivh/(Ivv+2Ivh)), corrected
for the g factor (hh/hv), were performed using an Excel
spreadsheet. Competitive equilibrium binding data were
analysed by an iterative fit to a single-site model using the
Excel Solver routine (Microsoft) in which the Kd for M32
was a free parameter, while that for F-M16N was fixed at
2 μM. The latter was determined by a fit to a hyperbola to
an independent titration in the absence of M32 (Fig. 2a)
under conditions where [F-M16N]=0.1 μM≪Kd). Note
that the small correction for the emission intensity
weighting to the observed anisotropy was not applied to
these competitive titrations as the error will tend to cancel.Stopped-flow spectroscopy
Stopped-flow measurements were carried out using an
SX18-MV apparatus (Applied Photophysics Ltd., Leather-
head, UK) with a dead time of 1.5 ms.40 Records were
generally captured on a logarithmic time base. Absorption
(turbidity) measurements were usually recorded using a
10-mm pathlength, while fluorescence was recorded with
a 2-mm pathlength for excitation and emission. The stated
concentrations of components refer to the reaction
chamber after mixing, unless otherwise indicated. Tyro-
sine fluorescence was excited at 280 nm, and the emission
was collected through a UG11 bandpass filter plus a
305-nm longpass filter.18 Fluorescein fluorescence was
excited at 480 nm, and the emission was detected through
a 515-nm longpass filter. Quin-2 fluorescence was mea-
sured by excitation at 336 nm, and emission was collected
with a 455-nm longpass filter. For simultaneous recording
of light scatter, a second channel was monitored through a
UG11 filter. Rate constants were obtained by fitting to
single-exponential or double-exponential functions using
Kaleidagraph (Synergy Software) or Applied Photophy-
sics Pro-Data software. Modeling of kinetic schemes was
performed using Berkeley Madonna software.Fluorescence microscopy
A clone of human epidermoid carcinoma A431/SIP1
cells,41 with constitutive expression of the GFP-tagged
heavy chain of nonmuscle myosin IIA, was used for FRAP
experiments. To generate the clone, we cotransfected
A431/SIP1 cells with pGFP-NMMII-A42 and pPuro, as
described previously.41 GFP-MHC-IIA expression was
confirmed by Western blot analysis with antibodies to
GFP (AMS Biotechnology, UK) and MHC-IIA (Covance,
Princeton, NJ). A431-SIP1 cells, stably expressing GFP–
nonmuscle myosin IIA, were seeded onmedium Y-shaped
micropatterns (CYTOO SA, Grenoble, France) following
the manufacturer's protocol and allowed to adhere for 3 h.
FRAPwas carried out using a custom-built total internal
reflection fluorescence (TIRF) apparatus based on a Zeiss
135 TV Axiovert microscope.43 Excitation light (488 nm,
15 mW) from an argon-ion laser (model 35LAP43; Melles
Griot, Huntingdon UK), after beam expansion to 6 mm
1024 S100A4-Myosin IIA Interactionsdiameter, was divided equally into two beams using a
nonpolarising prism beamsplitter. One beam was used to
image the GFP-labelled cell using prism-based TIRF, while
the second bleaching beam entered the back of the
objective lens (63× 1.2 NA Zeiss C-apochromat water
immersion) via the standard excitation path and was
brought to a point focus near the centre of the field. The
photobleaching beam had an independent aperture and
electronic shutter to control the profile of the bleaching
beam and the extent of bleaching. The specimen was
imaged using an iXon DV887 emCCD camera (Andor
Technology, UK) and translated at the manual stage until
the region of interest was in the predefined position of the
bleaching beam. The bleaching beam was generally
operated for 1–2 s, and images were acquired at 1-s
intervals thereafter.NMR spectroscopy
All NMR samples were prepared in 20 mM 4-
morpholineethanesulfonic acid, 20 mM NaCl, 5 mM
CaCl2, and 5% D2O buffer (pH 6.1). DTT (2 mM) was
added to the samples containing S100A4. Titration
experiments were carried out at 0.2 mM S100A4 using
10 mM peptide solutions. Spectra for M111 backbone
resonance assignments were measured using 0.4 mM
protein solution. NMR spectra were obtained at 298 K
using Bruker AVANCE DRX 600 or AVANCE DRX 800
spectrometers, which are both equipped with cryoprobes.
Proton chemical shifts were referenced to external 2,2-
dimethyl-2-silapentane-5-sulfonate. The 15N and 13C
chemical shifts were referenced indirectly using recom-
mended gyromagnetic ratios.44 Spectra were processed
with TopSpin (Bruker) and analysed using Analysis.45
Three-dimensional HNCO, HN(CA)CO, HNCA, HN(CO)
CA, HNCACB, and HN(CO)CACB experiments were
used for the sequential assignment of the backbone NH,
N, CO, Cα, and Cβ resonances.Electron microscopy
For negative staining, the stock solution of the M200
tail fragment was diluted with a solution consisting of
0.1 M Na-acetate, 3 mM MgCl2, 0.1 mM CaCl2, 10 mM
imidazole, and 5 mM NaH2PO4 (pH 7.0), with or
without 14 μM S100A4, to give a final concentration of
7 μM M200. Following dilution, 5 μl of the mixture was
applied to a grid with a thin carbon film supported by a
holey carbon film, and the grid was negatively stained
using 1% uranyl acetate. For metal shadowing, the stock
solutions of the M200 and M111 tail fragments were
diluted with 0.5 M ammonium acetate solution to give a
final concentration of 5 μM protein. This was mixed
with an equal volume of glycerol, and the resulting
mixture was sprayed onto freshly cleaved mica then
rotary shadowed with platinum at an angle of 6°.46
Grids were examined in a Philips CM120 electron
microscope (FEI, Hillsboro, OR) operated at 80 kV.
Images were recorded on a 2000×2000 F224HD slow-scan
CCD camera (TVIPS, Gauting, Germany) at amagnification
of 65,000× (0.37 nmpixel−1). The lengths of nonoverlapping
well-shadowed molecules were measured as described by
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